Search
for
Sort by
Research 811–840 of 1000+
- Birth, life, and death of the MAGE3 hypothesis of alopecia areata pathobiology
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- The Efficacy and Psychoneuroimmunology Mechanism of Camouflage Combined With Psychotherapy in Vitiligo Treatment
- Immune therapies for alopecia areata: evidence and new perspectives
- A Study of Correlation of Alopecia Areata and Metabolic Syndrome in Northwest Indian Population
- Hepatocyte growth factor combined with adenosine deaminase as biomarker for diagnosis of tuberculous pleural effusion
- A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- 51223 A novel human disease model of alopecia areata to evaluate benefit of the DHODH inhibitor farudodstat
- Preparation, solubility, and anti-inflammatory effects of a complex of diphenylcyclopropenone/β-cyclodextrin derivatives as the treatment of alopecia areata
- 90 Exploring the therapeutic potential of DHODH inhibitor farudodstat for alopecia areata treatment in a novel ex vivo model of human hair follicle immune privilege collapse
- The effect of 5-α reductase inhibitor on Th1, Th2, and Th17 cell-related inflammatory response in BPH
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata
- IL-15 in alopecia areata: the immune tolerance mechanistic insights and translational perspectives
- Potential Treatment of Steroid‐Resistant Alopecia Areata Using Allogeneic Exosomes Derived From Adipose Tissue Mesenchymal Stromal Cells: A Case Report
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- 455 Beyond Immunity: TEC and JAK3 Kinase Activation in Melanocytes Drives Inflammation in Vitiligo
- Exploring the Role of GLP‐1 Agents in Managing Diabetic Foot Ulcers: A Narrative and Systematic Review
- 0935 Unravelling the role of JAK3/TEC kinase signalling with ritlecitinib in alopecia areata lesional skin and alopecia areata-induced human hair follicles ex vivo
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides
- Unveiling the Effect of Age and IgE Level on Alopecia Areata: Insights from Comparative RNAseq Analysis
- Carotid Intima Media Thickness Measurement in Alopecia Areata Patients
- Immunological Abnormalities In PCOS
- Mesenchymal Stem Cell Therapy in Alopecia Areata: Visual and Molecular Evidence from a Mouse Model
- 290 Brepocitinib improves cicatricial alopecia and downregulates key T-helper biomarkers
- A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib
- A rare manifestation of STING-associated vasculopathy with onset in infancy: a case report